NaturalAntibody develops bioinformatics solutions to facilitate the process of engineering antibody-based therapeutics. The company collects, integrates, and repurposes antibody data points across public and proprietary repositories to learn about antibody structure, function, and diversity. Its solutions support researchers in making the process of designing therapeutic antibodies and drug discovery faster and safer.
Location: Poland, West Pomeranian Voivodeship, Szczecin
Employees: 11-50
Total raised: $1.7M
Investors 2
| Date | Name | Website |
| 07.09.2021 | Tar Heel C... | thcpathfin... |
| - | WP2 Invest... | wp2.invest... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 16.12.2021 | Grant | $1.7M | - |
Mentions in press and media 2
| Date | Title | Description |
| 09.05.2022 | Science and venture building – a match made in heaven. How NaturalAntibody is changing the pharmaceutical market | When did you decide to found NaturalAntibody? Konrad Krawczyk, PhD: The decision to found my own company was a long-term process and was maturing within me for many years. In 2009, after graduating from the University of Oxford with a degr... |
| 24.08.2021 | NaturalAntibody: Oxford scientist joins forces with Tar Heel Capital Pathfinder to revolutionise the process of drug manufacturing | NaturalAntibody helps IT-engineer therapeutic antibodies by discovering and optimizing those that may be used as drugs. To this end, it uses a proprietary database of previously neglected data on therapeutic antibodies together with custo... |